M06.31 Rheumatoid nodule, shoulder

Name of the Condition

• Rheumatoid nodule, shoulder

Summary

Rheumatoid nodule, shoulder is a localized extra-articular manifestation of rheumatoid arthritis (RA) involving firm, subcutaneous nodules in the shoulder region. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. They are associated with severe, long-standing RA, particularly in patients with high rheumatoid factor or anti-CCP antibody levels. The exact pathogenesis involves dysregulated immune responses and fibroblast activation, leading to nodule formation. They may also develop at sites of trauma or injection.

Risk Factors

• Severe, long-standing rheumatoid arthritis (especially seropositive disease).
• High rheumatoid factor or anti-CCP antibody titers.
• Presence of other extra-articular RA manifestations (e.g., vasculitis).
• Chronic inflammation and immune dysregulation.
• Trauma or pressure to affected areas.

Symptoms

• Firm, movable subcutaneous nodules in the shoulder area.
• Nodules may be painless or tender.
• May be associated with underlying shoulder joint inflammation or RA symptoms.

Diagnosis

Diagnosis relies on clinical evaluation, including physical examination of the shoulder nodules and correlation with the patient’s RA history. Imaging (e.g., ultrasound) may confirm subcutaneous tissue involvement, while blood tests (e.g., rheumatoid factor, anti-CCP) support the underlying RA diagnosis. Biopsy is rarely needed but can confirm histopathological features if atypical.

Treatment Options

Treatment focuses on managing underlying RA and reducing nodule-related symptoms. Options include:

• Disease-modifying antirheumatic drugs (DMARDs) to control systemic inflammation.
• Corticosteroid injections for localized pain or inflammation.
• Surgical excision for cosmetically bothersome or symptomatic nodules (rare).
• Pain management with NSAIDs or other analgesics as needed.

Prognosis and Follow-Up

Prognosis depends on the severity of underlying RA. Nodules may persist or fluctuate with disease activity. Regular follow-up with a rheumatologist is recommended to monitor RA progression and adjust treatment. Nodule size or number may change with effective RA therapy.

Complications

• Infection at the nodule site (rare).
• Ulceration or breakdown of overlying skin.
• Functional impairment if nodules affect shoulder mobility.
• Psychosocial impact due to cosmetic concerns.

Lifestyle & Prevention

• RA disease control is key to reducing nodule formation or progression.
• Avoid trauma or pressure to the shoulder area to minimize nodule development.
• Smoking cessation may lower risk, as smoking is linked to RA severity.
• Regular exercise to maintain shoulder mobility, as advised by a healthcare provider.

When to Seek Professional Help

Seek care if nodules become painful, increase in size, ulcerate, or are associated with new joint symptoms. Prompt evaluation is important if signs of infection (e.g., redness, warmth) or systemic RA flare occur.

Tips for Medical Coders

Document the location (shoulder) and correlation with rheumatoid arthritis. Ensure clinical notes specify the nodule’s presence and any associated RA activity. Code M06.31 is specific to shoulder involvement; verify no other extra-articular sites are documented to avoid miscoding.